Mydriasis Stability During Cataract Surgery in Patients with Systemic Comorbidities Using a Standardised Combination of Intracameral Mydriatics and Anaesthetic

Background: This study aimed to evaluate mydriasis stability during cataract surgery in patients with systemic comorbidities such as diabetes mellitus (DM) and pseudoexfoliation syndrome (PXF) after a standardised combination of intracameral mydriatics and anaesthetic (SCIMA). Stable mydriasis is cr...

Full description

Saved in:
Bibliographic Details
Main Authors: Joanna Dereń-Szumełda, Mariola Dorecka, Mirosław Dereń, Ewa Mrukwa-Kominek
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/15/1/119
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: This study aimed to evaluate mydriasis stability during cataract surgery in patients with systemic comorbidities such as diabetes mellitus (DM) and pseudoexfoliation syndrome (PXF) after a standardised combination of intracameral mydriatics and anaesthetic (SCIMA). Stable mydriasis is crucial for safe and effective phacoemulsification. Methods: Patients were included if they achieved pupil dilation ≥6.0 mm during the qualifying visit. A total of 103 patients were enrolled, divided into three groups: cataract with diabetes (C + DM group, <i>n</i> = 35), cataract with PXF (C + PXF group, <i>n</i> = 32), and cataract without those comorbidities (C group, <i>n</i> = 36). SCIMA was administered, and pupil diameters were measured at key surgical stages. Stability was defined as a pupil diameter of ≥6.0 mm without additional pharmacological intervention and no significant change in its diameter (≥3.0 mm). Results: Stable mydriasis was achieved in 90.3% of patients: 97.1% in the C + DM group, 90.6% in the C + PXF group, and 83.3% in the C group, with no statistically significant differences (<i>p</i> = 0.14). Conclusions: SCIMA effectively maintains mydriasis stability during cataract surgery, even in patients with systemic comorbidities, ensuring greater surgical safety.
ISSN:2075-1729